Enjoy complimentary customisation on priority with our Enterprise License!
The chemiluminescence analyzer market share is expected to increase by USD 5.31 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 9%.
This chemiluminescence analyzer market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers chemiluminescence analyzer market segmentation by product (benchtop CLA and floor-standing CLA), end-user (hospitals and diagnostic centers, research laboratories, pharma and biotech companies, and academic research centers), and geography (Europe, North America, APAC, and ROW). The chemiluminescence analyzer market report also offers information on several market vendors, including Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, Sysmex Corp., The Carlyle Group Inc., and Tosoh Corp. among others.
Download Report Sample to Unlock the Chemiluminescence Analyzer Market Size for the Forecast Period and Other Important Statistics
Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The increasing geriatric population is notably driving the chemiluminescence analyzer market growth, although factors such as lack of accessibility and affordability of diagnostic tests in developing countries may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the chemiluminescence analyzer industry. The holistic analysis of the drivers will help deduce end goals and refine marketing strategies to gain a competitive edge.
Key Chemiluminescence Analyzer Market Driver
The increasing geriatric population is one of the major drivers impacting the chemiluminescence analyzer market growth. Globally, there has been a rise in the elderly population. In 2018, the population of people aged 65 years and above accounted for 8.87% of the global population. Furthermore, there is a growing prevalence of both communicable diseases such as COVID-19, which is expected to accelerate the diagnosis and testing. Also, the probability of non-communicable diseases such as cancer, diabetes, cardiovascular disease, lung disease, cancer, and stroke increase with growing age, which drives the growth of the global chemiluminescence analyzer (CLA) market. Consequently, there is now a growing need associated with the global burden of disease to prevent, diagnose, and treat such chronic diseases. By 2030, the burden of non-communicable diseases in low and middle-income countries will be between 52% and 54%, while for communicable diseases, it will fall between 30% and 33%. In the case of the older population, non-communicable diseases account for approximately 85%-90% of the burden across countries and in all income groups.
Key Chemiluminescence Analyzer Market Trend
Increasing growth potential in emerging economies is one of the major trends influencing the chemiluminescence analyzer market growth. The growing demand for improving patient outcomes through advanced screening and diagnosis of diseases, rising healthcare expenditure, increasing number of hospitals, and increasing incidence of lifestyle disease is encouraging vendors to establish themselves in developing economies such as India and China, which offer substantial market opportunities. The increasing number of raw material suppliers, relatively low labor costs, and the low cost of raw materials are the major factors attracting established vendors and new entrants to expand their presence in emerging economies. Developing countries such as China and India have the largely untapped market potential for cancer and diabetes product manufacturers. The healthcare industry, including hospitals and clinics in developing economies, is growing at a tremendous pace, owing to the ongoing demographic shifts and rising healthcare expenditure. Moreover, advancements in pelvic floor diagnostics are gaining attention in these regions, with healthcare providers increasingly adopting modern diagnostic tools for conditions related to pelvic health.
Key Chemiluminescence Analyzer Market Challenge
The lack of accessibility and affordability of diagnostic tests in developing countries is one of the major challenges impeding the chemiluminescence analyzer market growth. High-quality diagnostic tests are easily available for various diseases in the majority of developed countries; however, they are neither affordable nor accessible in developing countries, where the disease burden is high. Management of disease by addressing symptoms is ineffective and increases the risk of antibiotic resistance. Therefore, evidence-based treatment is needed along with proper diagnostic testing for efficient disease management and developing therapies. Technology transfer and local production could be some possible strategies to address the various challenges affecting the diagnostics market in developing countries. However, the obstacles in the implementation of these practices have wide-reaching consequences and thus affect the overall well-being of the population in these countries. Pricing of diagnostic tests is a significant issue that vendors experience in countries such as India and China. The lack of a structured insurance program adds to the problem of pricing.
This chemiluminescence analyzer market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Technavio categorizes the global chemiluminescence analyzer (CLA) market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the chemiluminescence analyzer market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the chemiluminescence analyzer market encompasses successful business strategies deployed by the key vendors. The chemiluminescence analyzer market is fragmented and the vendors are deploying growth strategies such as R&D to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The chemiluminescence analyzer market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the leading companies' production, sustainability, and prospects.
Our report provides extensive information on the value chain analysis for the chemiluminescence analyzer market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the healthcare equipment market includes the following core components:
The report has further elucidated other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.